Feb 20, 2026 07:01AM

Feb 20, 2026 07:00AM

Feb 19, 2026 05:28AM

Feb 19, 2026 02:30AM

Feb 3, 2026 07:00AM

Feb 3, 2026 07:00AM

Feb 3, 2026 04:11AM FDA grants Priority Review to DATROWAY for metastatic breast cancer

Feb 3, 2026 02:30AM

Jan 19, 2026 02:30AM

Jan 13, 2026 07:00AM

Jan 13, 2026 07:00AM

Dec 22, 2025 07:01AM

Dec 22, 2025 07:00AM

Dec 22, 2025 05:40AM AstraZeneca's (AZN) ENHERTU receives breakthrough therapy designation for early breast cancer

Dec 22, 2025 02:30AM

Dec 22, 2025 02:30AM

Dec 22, 2025 02:30AM

Dec 15, 2025 04:29PM

Dec 15, 2025 04:29PM

Dec 15, 2025 02:30PM

Dec 15, 2025 02:30PM ENHERTU® Plus Pertuzumab Approved in the U.S. as First New Treatment in More Than a Decade for First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer

Dec 9, 2025 09:28AM

Dec 9, 2025 07:01AM

Dec 9, 2025 07:00AM

Dec 4, 2025 07:02AM

Dec 4, 2025 07:00AM

Dec 2, 2025 09:18AM

Dec 2, 2025 09:18AM Baxdrostat New Drug Application accepted under FDA Priority Review in the US for patients with hard-to-control hypertension

Dec 1, 2025 07:16AM

Nov 26, 2025 07:01AM

Nov 26, 2025 07:00AM

Nov 25, 2025 01:33PM

Nov 7, 2025 09:01AM

Nov 7, 2025 09:00AM

Nov 6, 2025 07:02AM Axsome Therapeutics acquires epilepsy drug candidate from AstraZeneca

Nov 6, 2025 07:00AM

Oct 30, 2025 09:00PM

Oct 30, 2025 09:00PM

Oct 19, 2025 07:00AM

Oct 19, 2025 02:30AM

Oct 18, 2025 10:35AM

Oct 18, 2025 10:30AM ENHERTU shows 67% response rate in breast cancer trial

Oct 18, 2025 10:30AM

Oct 18, 2025 10:30AM

Oct 18, 2025 10:30AM

Oct 18, 2025 10:30AM

Oct 17, 2025 04:17PM

Oct 17, 2025 04:11PM

Oct 17, 2025 10:00AM DATROWAY plus rilvegostomig shows tumor responses in urothelial cancer trial

Oct 17, 2025 10:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All